ARQT ▲ +1.8% - Arcutis Biotherapeutics, Inc.
$ARQT - Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
09-OCT-2026 08:00 AM ET
Share this post
More filings for $ARQT
ARQT ▲ +0.9% - Arcutis Biotherapeutics, Inc.Oct 9, 2026ARQT ▲ +0.4% - Arcutis Biotherapeutics, Inc.Oct 6, 2026ARQT - Arcutis Biotherapeutics, Inc. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026ARQT ▼ -0.6% - Arcutis Biotherapeutics, Inc.Oct 2, 2026ARQT ▲ +0.2% - Arcutis Biotherapeutics, Inc.Sep 29, 2026ARQT ▲ +1.0% - Arcutis Biotherapeutics, Inc.Sep 4, 2026
View full $ARQT filing history →💬 Comments
Loading comments…
Leave a comment